DOI:
10.1055/s-00025479
Experimental and Clinical Endocrinology & Diabetes Reports
LinksSchließen
Referenz
Salvatori R, Woodmansee WW, Molitch M. et al.
Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.
Pituitary 2014;
17: 13-21
Für die Inhalte der Internetseiten anderer Anbieter übernehmen wir keine Verantwortung.